Skip to main content
Erschienen in: Journal of Neurology 3/2013

01.03.2013 | Original Communication

Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study

verfasst von: Aurélie Ruet, Mathilde Deloire, Delphine Hamel, Jean-Christophe Ouallet, Klaus Petry, Bruno Brochet

Erschienen in: Journal of Neurology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

The association between cognitive impairment, health-related quality of life (HRQoL) and vocational status has been studied in recent years in cross-sectional studies in multiple sclerosis (MS), but longitudinal data are still lacking. This study assesses this association in a sample of 65 newly diagnosed MS patients followed longitudinally. Each patient underwent a standardised clinical assessment, cognitive tests and the HRQoL SEP-59 questionnaire six months after the MS diagnosis (baseline) and seven years later (y7).Vocational status was also established at baseline and at y7 in MS patients. The HRQoL at baseline was severely reduced in MS patients compared with healthy subjects. The independent predictors for HRQoL composite scores at y7 were the baseline depression score and the memory Z-score. Accordingly, 81.5 % of MS patients worked at baseline and only 54.4 % worked at y7. Among the MS patients who did not work at y7, 72.7 % of them were cognitively impaired, while 27.3 % were unimpaired at baseline. The vocational status at y7 was significantly associated with the baseline IPS Z-score, EDSS and age. Vocational status at y7 and its change over 7 years was significantly associated with cognitive deterioration. IPS or memory dysfunction in the early stages of MS is correlated with a decreased level in health perception, independent of fatigue, depression and physical disability. Cognitive impairment at the diagnosis of MS increases the risk of changing vocational status in MS patients seven years later.
Literatur
1.
Zurück zum Zitat Vernay D, Gerbaud L, Biolay S et al (2000) Quality of life and multiple sclerosis: validation of the French version of the self-questionnaire (SEP-59). Rev Neurol (Paris) 156:247–263 Vernay D, Gerbaud L, Biolay S et al (2000) Quality of life and multiple sclerosis: validation of the French version of the self-questionnaire (SEP-59). Rev Neurol (Paris) 156:247–263
2.
Zurück zum Zitat Mitchell AJ, Benito-León J, Morales González JM, Rivera-Navarro J (2005) Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 4:556–566PubMedCrossRef Mitchell AJ, Benito-León J, Morales González JM, Rivera-Navarro J (2005) Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 4:556–566PubMedCrossRef
3.
Zurück zum Zitat Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R et al (2005) Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 231:29–34PubMedCrossRef Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R et al (2005) Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 231:29–34PubMedCrossRef
4.
Zurück zum Zitat Brochet B (2011) Prevalence, profile and functional impact of cognitive impairment in multiple sclerosis. In: Amato MP (ed) Cognitive impairment in multiple sclerosis, Elsevier, Milano, pp 1–8 Brochet B (2011) Prevalence, profile and functional impact of cognitive impairment in multiple sclerosis. In: Amato MP (ed) Cognitive impairment in multiple sclerosis, Elsevier, Milano, pp 1–8
5.
Zurück zum Zitat Benito-León J, Morales JM, Rivera-Navarro J (2002) Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 9:497–502PubMedCrossRef Benito-León J, Morales JM, Rivera-Navarro J (2002) Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur J Neurol 9:497–502PubMedCrossRef
6.
Zurück zum Zitat Barker-Collo SL (2006) Quality of life in multiple sclerosis: does information-processing speed have an independent effect? Arch Clin Neuropsychol 21:167–174PubMedCrossRef Barker-Collo SL (2006) Quality of life in multiple sclerosis: does information-processing speed have an independent effect? Arch Clin Neuropsychol 21:167–174PubMedCrossRef
7.
Zurück zum Zitat Miller DM, Cohen JA, Kooijmans M, Tsao E, Cutter G, Baier M (2006) Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study. Mult Scler 12:180–186PubMedCrossRef Miller DM, Cohen JA, Kooijmans M, Tsao E, Cutter G, Baier M (2006) Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study. Mult Scler 12:180–186PubMedCrossRef
8.
Zurück zum Zitat Glanz BI, Healy BC, Rintell DJ, Jaffin SK, Bakshi R, Weiner HL (2010) The association between cognitive impairment and quality of life in patients with early multiple sclerosis. J Neurol Sci 290:75–79PubMedCrossRef Glanz BI, Healy BC, Rintell DJ, Jaffin SK, Bakshi R, Weiner HL (2010) The association between cognitive impairment and quality of life in patients with early multiple sclerosis. J Neurol Sci 290:75–79PubMedCrossRef
9.
Zurück zum Zitat Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41:692–696PubMedCrossRef Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41:692–696PubMedCrossRef
10.
Zurück zum Zitat Amato MP, Ponziani G, Siracusa G, Sorbi S (2001) Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 58:1602–1606PubMedCrossRef Amato MP, Ponziani G, Siracusa G, Sorbi S (2001) Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 58:1602–1606PubMedCrossRef
11.
Zurück zum Zitat Morrow SA, Drake A, Zivadinov R, Munschauer F, Weinstock-Guttman B, Benedict RH (2010) Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. Clin Neuropsychol 24:1131–1145PubMedCrossRef Morrow SA, Drake A, Zivadinov R, Munschauer F, Weinstock-Guttman B, Benedict RH (2010) Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. Clin Neuropsychol 24:1131–1145PubMedCrossRef
12.
Zurück zum Zitat de Groot V, Beckerman H, Lankhorst GJ, Polman CH, Bouter LM (2005) The initial course of daily functioning in multiple sclerosis: a three-year follow-up study. Mult Scler 11:713–718PubMedCrossRef de Groot V, Beckerman H, Lankhorst GJ, Polman CH, Bouter LM (2005) The initial course of daily functioning in multiple sclerosis: a three-year follow-up study. Mult Scler 11:713–718PubMedCrossRef
13.
Zurück zum Zitat Kern S, Schrempf W, Schneider H, Schultheiss T, Reichmann H, Ziemssen T (2009) Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis. Mult Scler 15:752–758PubMedCrossRef Kern S, Schrempf W, Schneider H, Schultheiss T, Reichmann H, Ziemssen T (2009) Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis. Mult Scler 15:752–758PubMedCrossRef
14.
Zurück zum Zitat Putzki N, Fischer J, Gottwald K, Reifschneider G, Ries S, Siever A et al (2009) Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. Eur J Neurol 16:713–720PubMedCrossRef Putzki N, Fischer J, Gottwald K, Reifschneider G, Ries S, Siever A et al (2009) Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis. Eur J Neurol 16:713–720PubMedCrossRef
15.
Zurück zum Zitat Patti F, Pozzilli C, Montanari E, Pappalardo A, Piazza L, Levi A et al (2007) Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Mult Scler 13:783–791PubMedCrossRef Patti F, Pozzilli C, Montanari E, Pappalardo A, Piazza L, Levi A et al (2007) Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Mult Scler 13:783–791PubMedCrossRef
16.
Zurück zum Zitat Deloire MS, Salort E, Bonnet M, Arimone Y, Boudineau M, Amieva H et al (2005) Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. JNNP 76:519–526 Deloire MS, Salort E, Bonnet M, Arimone Y, Boudineau M, Amieva H et al (2005) Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. JNNP 76:519–526
17.
Zurück zum Zitat Deloire MS, Ruet A, Hamel D, Bonnet M, Dousset V, Brochet B (2011) MRI predictors of cognitive outcome in early multiple sclerosis. Neurology 76:1161–1167PubMedCrossRef Deloire MS, Ruet A, Hamel D, Bonnet M, Dousset V, Brochet B (2011) MRI predictors of cognitive outcome in early multiple sclerosis. Neurology 76:1161–1167PubMedCrossRef
18.
Zurück zum Zitat Poser CM, Paty DW, Scheinberg L et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research proposals. Ann Neurol 13:227–231 Poser CM, Paty DW, Scheinberg L et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research proposals. Ann Neurol 13:227–231
19.
Zurück zum Zitat Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 46:907–911PubMedCrossRef Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 46:907–911PubMedCrossRef
20.
Zurück zum Zitat Gayou A, Brochet B, Dousset V (1997) Transitional progressive multiple sclerosis: a clinical and imaging study. JNNP 63:396–398 Gayou A, Brochet B, Dousset V (1997) Transitional progressive multiple sclerosis: a clinical and imaging study. JNNP 63:396–398
21.
Zurück zum Zitat Leplège A, Ecosse E, Coste J, Pouchot J, Perneger T (2001) Le questionnaire MOS SF-36: manuel de l’utilisateur et guide d’interprétation des scores. Editions Estem, Paris Leplège A, Ecosse E, Coste J, Pouchot J, Perneger T (2001) Le questionnaire MOS SF-36: manuel de l’utilisateur et guide d’interprétation des scores. Editions Estem, Paris
22.
Zurück zum Zitat Vickrey BG (1995) Multiple sclerosis quality of life (MSQOL)-54 instrument. University of California, Los Angeles Vickrey BG (1995) Multiple sclerosis quality of life (MSQOL)-54 instrument. University of California, Los Angeles
23.
Zurück zum Zitat Deloire MS, Bonnet MC, Salort E, Arimone Y, Boudineau M, Petry KG et al (2006) How to detect cognitive dysfunction at early stages of multiple sclerosis? Mult Scler 12:445–452PubMedCrossRef Deloire MS, Bonnet MC, Salort E, Arimone Y, Boudineau M, Petry KG et al (2006) How to detect cognitive dysfunction at early stages of multiple sclerosis? Mult Scler 12:445–452PubMedCrossRef
24.
Zurück zum Zitat de Groot V, Beckerman H, Uitdehaag BM, de Vet HC, Lankhorst GJ, Polman CH et al (2006) The usefulness of evaluative outcome measures in patients with multiple sclerosis. Brain 129:2648–2659PubMedCrossRef de Groot V, Beckerman H, Uitdehaag BM, de Vet HC, Lankhorst GJ, Polman CH et al (2006) The usefulness of evaluative outcome measures in patients with multiple sclerosis. Brain 129:2648–2659PubMedCrossRef
25.
Zurück zum Zitat Deloire M, Ruet A, Hamel D, Bonnet M, Brochet B (2010) Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult Scler 16:581–587PubMedCrossRef Deloire M, Ruet A, Hamel D, Bonnet M, Brochet B (2010) Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult Scler 16:581–587PubMedCrossRef
26.
Zurück zum Zitat Strober LB, Christodoulou C, Benedict RH, Westervelt HJ, Melville P, Scherl WF, Weinstock-Guttman B, Rizvi S, Goodman AD, Krupp LB (2012) Unemployment in multiple sclerosis: the contribution of personality and disease. Mult Scler 18(5):647–653PubMedCrossRef Strober LB, Christodoulou C, Benedict RH, Westervelt HJ, Melville P, Scherl WF, Weinstock-Guttman B, Rizvi S, Goodman AD, Krupp LB (2012) Unemployment in multiple sclerosis: the contribution of personality and disease. Mult Scler 18(5):647–653PubMedCrossRef
27.
Zurück zum Zitat Simmons RD, Tribe KL, McDonald EA (2010) Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management. J Neurol 257(6):926–936PubMedCrossRef Simmons RD, Tribe KL, McDonald EA (2010) Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management. J Neurol 257(6):926–936PubMedCrossRef
Metadaten
Titel
Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study
verfasst von
Aurélie Ruet
Mathilde Deloire
Delphine Hamel
Jean-Christophe Ouallet
Klaus Petry
Bruno Brochet
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 3/2013
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6705-1

Weitere Artikel der Ausgabe 3/2013

Journal of Neurology 3/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.